Terms: = Lung cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
955 results:
1. Plexiform Fibromyxoma in the Stomach: Immunohistochemical Profile and Comprehensive Genetic Characterization.
Di Mauro A; Rega RA; Leongito M; Albino V; Palaia R; Gualandi A; Belli A; D'Arbitrio I; Moccia P; Tafuto S; De Chiara A; Ottaiano A; Ferrara G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732067
[TBL] [Abstract] [Full Text] [Related]
2. Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
Han R; Guo H; Shi J; Zhao S; Jia Y; Liu X; Liu Y; Cheng L; Zhao C; Li X; Zhou C
BMC Med; 2024 Apr; 22(1):174. PubMed ID: 38658988
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
[TBL] [Abstract] [Full Text] [Related]
4. Validation of the lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
Carril-Ajuria L; Lavaud P; Dalban C; Negrier S; Gravis G; Motzer RJ; Chevreau C; Tannir NM; Oudard S; McDermott DF; Laguerre B; Hammers HJ; Barthelemy P; Plimack ER; Borchiellini D; Gross-Goupil M; Jiang R; Lee CW; de Silva H; Rini BI; Escudier B; Albigès L
Eur J Cancer; 2024 Jun; 204():114048. PubMed ID: 38653033
[TBL] [Abstract] [Full Text] [Related]
5. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
Thangavel SK; Mohamed Kasim MS; Rengan R
Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
[TBL] [Abstract] [Full Text] [Related]
6. Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and cancer.
Chiappalupi S; Salvadori L; Borghi M; Mancuso F; Pariano M; Riuzzi F; Luca G; Romani L; Arato I; Sorci G
Cells; 2024 Mar; 13(6):. PubMed ID: 38534388
[TBL] [Abstract] [Full Text] [Related]
7. Recent development of vegfr small molecule inhibitors as anticancer agents: A patent review (2021-2023).
Zeng J; Deng Q; Chen Z; Yan S; Dong Q; Zhang Y; Cui Y; Li L; He Y; Shi J
Bioorg Chem; 2024 May; 146():107278. PubMed ID: 38484586
[TBL] [Abstract] [Full Text] [Related]
8. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors.
Hussain S; Mursal M; Verma G; Hasan SM; Khan MF
Eur J Pharmacol; 2024 May; 970():176484. PubMed ID: 38467235
[TBL] [Abstract] [Full Text] [Related]
9. Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/vegfr Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors.
Hu Y; Narayan A; Xu Y; Wolfe J; Vu D; Trinh T; Kantak C; Ivy SP; Eder JP; Deng Y; LoRusso P; Kim JW; Patel AA
JCO Precis Oncol; 2024 Feb; 8():e2300289. PubMed ID: 38412387
[TBL] [Abstract] [Full Text] [Related]
10. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.
Liu M; Li H; Guo R; Yu X; Li Y
Clin Respir J; 2024 Feb; 18(2):e13738. PubMed ID: 38403875
[TBL] [Abstract] [Full Text] [Related]
11. vegfr affects miR-3200-3p-mediated regulatory T cell senescence in tumour-derived exosomes in non-small cell lung cancer.
Hui K; Dong C; Hu C; Li J; Yan D; Jiang X
Funct Integr Genomics; 2024 Feb; 24(2):31. PubMed ID: 38363405
[TBL] [Abstract] [Full Text] [Related]
12. Hexane Fraction of
Park HJ; Jeong JH; Choi YH; Park SH
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338342
[TBL] [Abstract] [Full Text] [Related]
13. NKX2-1-AS1 promotes the lymphangiogenesis of lung adenocarcinoma through regulation of ERG-mediated FABP4.
Tao T; Chen H; Xu Q; Li Z; Chen X; Zhou X; Luo W
Tissue Cell; 2024 Apr; 87():102314. PubMed ID: 38309204
[TBL] [Abstract] [Full Text] [Related]
14. Chemosensitization of non-small cell lung cancer to sorafenib via non-hydroxamate s-triazinedione-based MMP-9/10 inhibitors.
Khalil HH; El-Sheshtawy MM; Khattab SN; Abu-Serie MM; Shehat MG; Teleb M; Haiba NS
Bioorg Chem; 2024 Mar; 144():107155. PubMed ID: 38306827
[TBL] [Abstract] [Full Text] [Related]
15. Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
Beckermann KE; Asnis-Alibozek AG; Atkins MB; Escudier B; Hutson TE; Kasturi V; McDermott DF; Pal SK; Porta C; Rini BI; Verzoni E
Oncologist; 2024 Mar; 29(3):254-262. PubMed ID: 38262444
[TBL] [Abstract] [Full Text] [Related]
16. β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic lung cancer Cells-Possible Role of VEGF Downregulation.
Wittig F; Koch F; Pannenberg L; Bekeschus S; Ramer R; Hinz B
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255884
[TBL] [Abstract] [Full Text] [Related]
17. Iodoquinazoline-derived vegfr-2 and EGFR
Mohamed AA; El-Hddad SSA; Aljohani AKB; Khedr F; Alatawi OM; Keshek DE; Ahmed S; Alsulaimany M; Almadani SA; El-Adl K; Hanafy NS
Bioorg Chem; 2024 Feb; 143():107062. PubMed ID: 38150938
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
19. Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic lung cancer Cells.
Wittig F; Pannenberg L; Schwarz R; Bekeschus S; Ramer R; Hinz B
Cells; 2023 Sep; 12(19):. PubMed ID: 37830546
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer.
Chen D; Li L; Wang M; Hu X; Jiang J; Li W; Yang L; Fan M; Shi Y; Lv F; Liu Y
Front Immunol; 2023; 14():1086479. PubMed ID: 37795095
[TBL] [Abstract] [Full Text] [Related]
[Next]
